Compare INBX & CBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INBX | CBL |
|---|---|---|
| Founded | 2010 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2024 | 1995 |
| Metric | INBX | CBL |
|---|---|---|
| Price | $84.95 | $46.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $266.67 | $63.00 |
| AVG Volume (30 Days) | ★ 268.9K | 216.0K |
| Earning Date | 11-17-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 5.58% |
| EPS Growth | N/A | ★ 132.09 |
| EPS | N/A | ★ 2.95 |
| Revenue | $1,300,000.00 | ★ $578,373,000.00 |
| Revenue This Year | N/A | $1.32 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $16.85 |
| Revenue Growth | ★ 550.00 | 12.18 |
| 52 Week Low | $57.30 | $31.65 |
| 52 Week High | $155.29 | $60.40 |
| Indicator | INBX | CBL |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 33.79 |
| Support Level | $71.37 | $46.78 |
| Resistance Level | $86.61 | $48.91 |
| Average True Range (ATR) | 8.14 | 1.35 |
| MACD | 0.17 | -0.05 |
| Stochastic Oscillator | 51.02 | 9.22 |
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.